Illumina (ILMN) Optics for Genomics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Illumina (ILMN) Optics for Genomics

ILMN 122.42

+4.7%

Nov 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Elmer who started this subject	6/3/2003 8:32:01 PM
From: mopgcw	of 276

Illumina to Webcast Presentation at the Goldman Sachs 24th Annual Global Healthcare Conference Businesswire, Tuesday, June 03, 2003 at 16:42 SAN DIEGO, Jun 3, 2003 (BUSINESS WIRE) -- Illumina, Inc. (Nasdaq: ILMN) announced today that Jay Flatley, President and CEO, will present an overview of Company operations and recent product development activity at the Goldman Sachs 24th Annual Global Healthcare Conference in Dana Point, California. Mr. Flatley's live presentation will be transmitted on the web beginning on or about 8:20 a.m. on Thursday, June 12. The webcast can be accessed at the address below. The webcast will be archived for 30 days at the same address: customer.nvglb.com Illumina (www.illumina.com) is developing next-generation tools that permit large-scale analysis of genetic variation and function. The Company's proprietary BeadArray(TM) technology provides the throughput, cost effectiveness and flexibility to enable researchers in the life sciences and pharmaceutical industries to perform the billions of tests necessary to extract medically valuable information from advances in genomics. This information will help pave the way to personalized medicine.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next